OMTX 703

Drug Profile

OMTX 703

Alternative Names: MTX3-CYT; OMTX-703

Latest Information Update: 27 Jul 2016

Price : $50

At a glance

  • Originator Oncomatryx
  • Class Antineoplastics; Immunoconjugates
  • Mechanism of Action Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Ewing's sarcoma; Pancreatic cancer

Most Recent Events

  • 27 Jul 2016 Early research in Pancreatic cancer in Spain (unspecified route)
  • 27 Jul 2016 Early research in Ewing's Sarcoma in Spain (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top